Esperion Therapeutics Inc at JPMorgan Healthcare Conference Transcript
&-
I'm a senior biotech analyst at JPMorgan, and we're continuing the Health Care conference today with Esperion. I'm joined upfront by the Company's CEO, Sheldon Koenig and he's going to have a presentation on the business and then we're going to go into Q&A. If you've got a question in the room, raise your hand, we'll get you a mike or you can submit questions to me via the portal and I will read them of the iPad up here. So with that, let me pass it over to Sheldon.
Great. Thank you, Jess. And first of all on behalf of Esperion and the company. Thank you to JPMorgan for allowing us to have the opportunity to talk about Esperion. Really exciting business, we'll talk about that in a few seconds look forward to Q&A that you may have. So I think we're taking Q&A online and also in the room, there's a microphone that will be available in the room. So thank you again for your attention.
And forward-looking statement,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |